Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region by G.B. Migliori, O. Korotych, J. Achar, A. Ciobanu, G. Dravniece, M. Germanovych, E. Gurbanova, A. Hovhannesyan, N. Khachatryan, L. Kuksa, N. Lomtadze, M.L. Rich, A. Skrahina, A. Yedilbayev

Get full text

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy by L. Kuksa, C. Andrejak, B. Haecker, G. Bothamley, A. Calcagno, D.M. Cirillo, R. Duarte, R. Fatima, G. Ferlazzo, L. Guglielmetti, G. Günther, C. Hewison, C.R. Horsburgh, T. Jäger, Y. Kalancha, R. Otto-Knapp, K. Kranzer, T. Lillebaek, G. Marks, K. Middelkoop, I. Motta, V. Rabinova, P. Sommerfeld, P. Tattevin, C. Lange

Get full text

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe by O. Kirakosyan, M. Reimann, A.B. Andersen, A. Bjarnason, Á. Bakos, A.M. Dyrhol-Riise, A.M. McLaughlin, C. Nita, D. Pieridou, D. Chesov, E.V. Davidavičienė, G. Günther, H. Atshemyan, I. Muylle, I. Solovic, J. Bruchfeld, K. Manika, L. Kuksa, L.R. Codecasa, M. Stosic, M. Skowroński, M.J. Makek, M. Fréchet Jachym, M. Knappik, M. Santin, N. Yatskevich, O. Konstantynovska, O. Akkerman, P. Svetina, P. Viiklepp, R. Duarte, S. Zeynel, T. Togonidze, T. Vasankari, V. Parris, Ş. Özkara, C. Lange, T.T. Brehm

Get full text